National Academies Press: OpenBook
« Previous: K Conversion of Units
Suggested Citation:"L Options for Dealing with Uncertainties." Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press. doi: 10.17226/10026.
×
Page 710
Suggested Citation:"L Options for Dealing with Uncertainties." Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press. doi: 10.17226/10026.
×
Page 711
Suggested Citation:"L Options for Dealing with Uncertainties." Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press. doi: 10.17226/10026.
×
Page 712
Suggested Citation:"L Options for Dealing with Uncertainties." Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press. doi: 10.17226/10026.
×
Page 713
Suggested Citation:"L Options for Dealing with Uncertainties." Institute of Medicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press. doi: 10.17226/10026.
×
Page 714

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

L Options for Dealing with Uncertainties Methods for dealing with uncertainties in scientific data are gen- erally understood by working scientists and require no special dis- cussion here except to point out that such uncertainties should be explicitly acknowledged and taken into account whenever a risk assessment is undertaken. More subtle and difficult problems are created by uncertainties associated with some of the inferences that must be made in the absence of directly applicable data; much confusion and inconsistency can result if they are not recognized and dealt with in advance of undertaking a risk assessment. The most significant inference uncertainties arise in risk assess- ments whenever attempts are made to answer the following ques- tions (NRC, 1994): • What set or sets of hazard and dose-response data (for a given substance) should be used to characterize risk in the population of interest? • If animal data are to be used for risk characterization, which endpoints for adverse effects should be considered? • If animal data are to be used for risk characterization, what measure of dose (e.g., dose per unit body weight, body surface, or dietary intake) should be used for scaling between animals and humans? • What is the expected variability in dose-response between ani- mals and humans? • If human data are to be used for risk characterization, which adverse effects should be used? 710

APPENDIX L 711 • What is the expected variability in dose-response among members of the human population? • How should data from subchronic exposure studies be used to estimate chronic effects? • How should problems of differences in route of exposure within and between species be dealt with? • How should the threshold dose be estimated for the human population? • If a threshold in the dose-response relationship seems unlikely, how should a low-dose risk be modeled? • What model should be chosen to represent the distribution of exposures in the population of interest when data relating to expo- sures are limited? • When interspecies extrapolations are required, what should be assumed about relative rates of absorption from the gastrointestinal tract of animals and of humans? • For which percentiles on the distribution of population expo- sures should risks be characterized? At least partial, empirically based answers to some of these ques- tions may be available for some of the nutrients under review, but in no case is scientific information likely to be sufficient to provide a highly certain answer; in many cases there will be no relevant data for the nutrient in question. It should be recognized that for several of these questions, certain inferences have been widespread for long periods of time; thus, it may seem unnecessary to raise these uncertainties anew. When sev- eral sets of animal toxicology data are available, for example, and data are not sufficient for identifying the set (i.e., species, strain, and adverse effects endpoint) that best predicts human response, it has become traditional to select that set in which toxic responses occur at lowest dose (the most sensitive set). In the absence of definitive empirical data applicable to a specific case, it is generally assumed that there will not be more than a ten-fold variation in response among members of the human population. In the absence of absorption data, it is generally assumed that humans will absorb the chemical at the same rate as the animal species used to model human risk. In the absence of complete understanding of biological mechanisms, it is generally assumed that, except possibly for certain carcinogens, a threshold dose must be exceeded before toxicity is expressed. These types of long-standing assumptions, which are nec- essary to complete a risk assessment, are recognized by risk assessors as attempts to deal with uncertainties in knowledge (NRC, 1994).

712 DIETARY REFERENCE INTAKES A past National Research Council (NRC) report (1983) recom- mended adoption of the concepts and definitions that have been discussed in this report. The NRC committee recognized that through- out a risk assessment, data and basic knowledge will be lacking and risk assessors will be faced with several scientifically plausible options (called inference options by the NRC) for dealing with questions such as those presented above. For example, several scientifically supportable options for dose scaling across species and for high- to low-dose extrapolation will exist, but there will be no ready means to identify those that are clearly best supported. The NRC commit- tee recommended that regulatory agencies in the United States identify the needed inference options in risk assessment and specify, through written risk assessment guidelines, the specific options that will be used for all assessments. Agencies in the United States have identified the specific models to be used to fill gaps in data and knowledge; these have come to be called default options (EPA, 1986). The use of defaults to fill knowledge and data gaps in risk assess- ment has the advantage of ensuring consistency in approach (the same defaults are used for each assessment) and minimizing or elim- inating case-by-case manipulations of the conduct of risk assessment to meet predetermined risk management objectives. The major dis- advantage of the use of defaults is the potential for displacement of scientific judgment by excessively rigid guidelines. A remedy for this disadvantage was also suggested by the NRC committee: risk assessors should be allowed to replace defaults with alternative fac- tors in specific cases of chemicals for which relevant scientific data are available to support alternatives. The risk assessors’ obligation in such cases is to provide explicit justification for any such depar- ture. Guidelines for risk assessment issued by the U.S. Environ- mental Protection Agency (EPA, 1986), for example, specifically allow for such departures. The use of preselected defaults is not the only way to deal with model uncertainties. Another option is to allow risk assessors com- plete freedom to pursue whatever approaches they judge applicable in specific cases. Because many of the uncertainties cannot be re- solved scientifically, case-by-case judgments without some guidance on how to deal with them will lead to difficulties in achieving scien- tific consensus, and the results of the assessment may not be credible. Another option for dealing with uncertainties is to allow risk assessors to develop a range of estimates based on application of both defaults and alternative inferences that, in specific cases, have some degree of scientific support. Indeed, appropriate analysis of

APPENDIX L 713 uncertainties seems to require such a presentation of risk results. Although presenting a number of plausible risk estimates has the advantage that it would seem to more faithfully reflect the true state of scientific understanding, there are no well-established criteria for using such complex results in risk management. The various approaches to dealing with uncertainties inherent in risk assessment are summarized in Table L-1. As can be seen in the nutrient chapters, specific default assump- tions for assessing nutrient risks have not been recommended. Rather, the approach calls for case-by-case judgments, with the recommen- dation that the basis for the choices made be explicitly stated. Some general guidelines for making these choices are, however, offered. TABLE L-1 Approaches for Dealing with Uncertainties in a Risk Assessment Program Program Model Advantages Disadvantages Case-by-case Flexibility; high Potential for inconsistent judgments by potential to maximize treatment of different experts use of most relevant issues; difficulty in scientific information achieving consensus; bearing on specific need to agree on issues defaults Written guidelines Consistent treatment of Possible difficulty in specifying defaults different issues; justifying departure or for data and model maximization of achieving consensus uncertainties (with transparency of among scientists that allowance for process; resolution of departures are justified departures in scientific disagreements in specific cases; danger specific cases) possible by resort to that uncertainties will be defaults overlooked Presentation of full Maximization of use of Highly complex array of estimates scientific information; characterization of risk, from all scientifically reasonably reliable with no easy way to plausible models portrayal of true state discriminate among by assessors of scientific estimates; size of understanding required effort may not be commensurate with utility of the outcome

714 DIETARY REFERENCE INTAKES REFERENCES EPA (US Environmental Protection Agency). 1986. Proposed guidelines for car- cinogen risk assessment; Notice. Fed Regis 61:17960–18011. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press. NRC. 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.

Next: M Biographical Sketches of Panel and Subcommittee Members »
Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc Get This Book
×

This volume is the newest release in the authoritative series issued by the National Academy of Sciences on dietary reference intakes (DRIs). This series provides recommended intakes, such as Recommended Dietary Allowances (RDAs), for use in planning nutritionally adequate diets for individuals based on age and gender. In addition, a new reference intake, the Tolerable Upper Intake Level (UL), has also been established to assist an individual in knowing how much is "too much" of a nutrient.

Based on the Institute of Medicine's review of the scientific literature regarding dietary micronutrients, recommendations have been formulated regarding vitamins A and K, iron, iodine, chromium, copper, manganese, molybdenum, zinc, and other potentially beneficial trace elements such as boron to determine the roles, if any, they play in health. The book also:

  • Reviews selected components of food that may influence the bioavailability of these compounds.
  • Develops estimates of dietary intake of these compounds that are compatible with good nutrition throughout the life span and that may decrease risk of chronic disease where data indicate they play a role.
  • Determines Tolerable Upper Intake levels for each nutrient reviewed where adequate scientific data are available in specific population subgroups.
  • Identifies research needed to improve knowledge of the role of these micronutrients in human health.

This book will be important to professionals in nutrition research and education.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!